Pacific Adult Congenital Heart Disease Clinic, Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Pacific Adult Congenital Heart Disease Clinic, Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Int J Cardiol. 2017 Dec 1;248:131-135. doi: 10.1016/j.ijcard.2017.08.007. Epub 2017 Aug 5.
In a cohort of congenitally corrected transposition of the great arteries (cc-TGA) and transposition of the great arteries after atrial switch procedure (d-TGA) the study objectives were: 1) to assess the change of quantitative systemic right ventricle (sRV) parameters over time and; 2) to examine the relationship of quantitative sRV parameters with adverse clinical outcomes.
Single-center cohort study that included 49 (39%) cc-TGA and 76 (61%) d-TGA patients >18years who had at least one MUGA sRV assessment, 18/39 had more than one respectively. The primary clinical endpoint was all-cause mortality, heart transplantation and/or heart failure hospitalization. At a median clinical follow-up of 7years following the first MUGA, the primary endpoint occurred more often in cc-TGA versus d-TGA patients (18 (36.7%) vs. 9 (11.8%), p=0.03). Median time between the MUGA assessments was 5.8 (cc-TGA) and 4.9years (d-TGA). At last MUGA follow-up: 6 (33%) cc-TGA/14 (36%) d-TGA patients showed a significant decline in sRVEF (>5%); 6 (33%) cc-TGA/17 (44%) d-TGA patients had a significant increase in sRVEDVi; and 7 (39%) cc-TGA/19 (49%) PA-TGA patients had a significant increase in sRVESVi. Baseline sRV parameters were not associated with the primary end point or sRV changes over time.
An important proportion of both patient cohorts demonstrated a significant change in sRV parameters over time and these are likely related to multiple factors that vary between individuals given population heterogeneity. The TGA patients have distinct clinical trajectories with increased adverse heart failure outcomes in the cc-TGA population and sRV parameters were not related to adverse heart failure events in either group.
在一组先天性矫正大动脉转位(cc-TGA)和大动脉调转术后(d-TGA)患者中,研究目的是:1)评估定量右心室(sRV)参数随时间的变化;2)检查定量 sRV 参数与不良临床结局的关系。
这是一项单中心队列研究,纳入了 49 例(39%)cc-TGA 和 76 例(61%)d-TGA 患者,这些患者年龄均>18 岁,且至少有一次 MUGA sRV 评估,其中 18/39 例患者有多次评估。主要临床终点是全因死亡率、心脏移植和/或心力衰竭住院。在首次 MUGA 检查后的中位临床随访 7 年后,cc-TGA 患者的主要终点发生率高于 d-TGA 患者(18 [36.7%] vs. 9 [11.8%],p=0.03)。两次 MUGA 检查之间的中位时间为 5.8 年(cc-TGA)和 4.9 年(d-TGA)。在最后一次 MUGA 随访时:6 例(33%)cc-TGA/14 例(36%)d-TGA 患者的 sRVEF 显著下降(>5%);6 例(33%)cc-TGA/17 例(44%)d-TGA 患者的 sRVEDVi 显著增加;7 例(39%)cc-TGA/19 例(49%)PA-TGA 患者的 sRVESVi 显著增加。基线 sRV 参数与主要终点或随时间变化的 sRV 无显著相关性。
两组患者的重要比例都随时间出现了 sRV 参数的显著变化,这可能与个体之间的多种因素有关,因为人群存在异质性。TGA 患者的临床轨迹不同,cc-TGA 患者的心力衰竭不良结局增加,而 sRV 参数与两组患者的心力衰竭不良事件均无显著相关性。